Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. Ani ...
According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $555.7 ...
Polyethylene glycol (PEG) 3350; pwd for reconstitution. Polyethylene glycol 3350 cleanses the bowel by induction of diarrhea. The osmotic activity of polyethylene glycol 3350, in combination with the ...
https://www.thehindubusinessline.com/markets/stock-markets/glenmark-launches-over-the-counter-laxative-to-compete-with-miralax/article69312141.ece Copy Glenmark ...
NEW YORK, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Polyethylene Glycol Market" with 100+ market data tables, pie charts, graphs, and figures ...
(MENAFN- Adfactors PR) Bengaluru, March 10, 2025: Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); ...
Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of polyethylene glycol 3350, powder for solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX powder for solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results